{{cart_num}}
My CartCAS：14222-60-7
Molecular Formula：C9H12N2S
Molecular Weight：180.27
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Light yellow to yellow Solid
Qty：
Size：
| CAS | 14222-60-7 |
| Name | Protionamide |
| Molecular Formula | C9H12N2S |
| Molecular Weight | 180.27 |
| Solubility | Soluble in DMSO(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | Light yellow to yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 238-093-7 |
| MDL | MFCD00464119 |
| SMILES | CCCC1=NC=CC(=C1)C(=S)N |
| InChIKey | VRDIULHPQTYCLN-UHFFFAOYSA-N |
| InChI | InChI=1S/C9H12N2S/c1-2-3-8-6-7(9(10)12)4-5-11-8/h4-6H，2-3H2，1H3，(H2，10，12) |
| PubChem CID | 666418 |
| Target Point | Bacterial |
| Passage | Anti-infection |
| Background | It has antituberculous activity and can be used in the treatment of tuberculosis. |
| Biological Activity | Protionamide 是一种用于治疗肺结核的药物，也被用于治疗麻风病。[1-2] |
| Data Literature Source | [1]. Wang F，et al. Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med. 2007 Jan 22;204(1):73-8. [2]. Fajardo TT，et al. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy. Am J Trop Med Hyg. 2006 Mar;74(3):457-61. |
| Unit | Bottle |
| Specification | 50mg 100mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
